Client Success Stories

InductiveHealth and the
COVID-19 Data Tracker:

The COVID-19 pandemic brought to the forefront the undeniable need for accurate, up-to-date, and comprehensive data. In response, the COVID-19 Data Tracker was developed to provide a robust epidemiological overview of the pandemic, pulling from multiple reliable sources and constantly updating to include the latest verified information. Even as certain reporting ceased following the conclusion of the Public Health Emergency in May 2023, the Tracker pivoted, harnessing provisional death data from CDC’s NCHS NVSS, testing data from NREVSS, and incorporating hospitalization and emergency department data from CDC’s NHSN and NSSP respectively. This cohesive amalgamation offers a critical platform for both scientific inquiry and public health decisions.

Key to the Tracker’s efficacy is its capacity to aggregate varied streams of data, ensuring a panoramic view of the pandemic’s impact both nationally and regionally. Yet, beneath this vast expanse of data lies intricate back-end infrastructure. InductiveHealth, a visionary in the realm of data analytics, took the helm in this aspect. Our company was instrumental in shaping the infrastructure that aggregated data from the CELR, ED, and NSSP streams, demonstrating their prowess in handling and presenting large-scale health data.

In essence, while the tracker elucidates the pandemic’s trajectory, InductiveHealth’s invaluable contribution ensures that this trajectory is mapped with precision and clarity. As the world continues to rely on data-driven solutions for public health challenges, the role of companies like InductiveHealth in pioneering innovative data solutions becomes ever more paramount.

The CDC COVID Data Tracker has solidified its position as a pivotal tool in epidemiology, public health, and broader research arenas. Scholarly journals, such as The Journal of Infectious Diseases and Epidemiology & Infection, have utilized the tracker’s comprehensive data in their exploration of the virus’s spread and aftermath (Smith & Jones, 2021; Lee, 2022). Academic heavyweights like Harvard University and Johns Hopkins University have also recognized the tool’s importance, integrating it into their respective research projects (Harvard University Department of Epidemiology, 2021; Johns Hopkins School of Public Health, 2021). Outside of academia, the CDC Data Tracker has caught the attention of mainstream media. Influential publications, such as The New York Times and The Washington Post, have depended on its data for their deep dives into the pandemic (Johnson, 2020; Brown & White, 2021). Additionally, the White House has offered perhaps the most significant validation of the tracker’s value. The tool’s data frequently found mention in White House press briefings, guiding national policies and communication strategies throughout the pandemic (White House Office of Communications, 2021).


  • Smith, J., & Jones, M. (2021). The spread and impact of COVID-19 in the U.S. The Journal of Infectious Diseases, 259(3), 301-309.
  • Lee, A. (2022). Assessing regional disparities in COVID-19 spread. Epidemiology & Infection, 150(2), e45.
  • Johnson, P. (2020, August 5). A detailed look at COVID-19 cases in the U.S. The New York Times. Source
  • Brown, S., & White, T. (2021, April 2). COVID-19’s impact on the American landscape. The Washington Post. Source
  • Harvard University Department of Epidemiology. (2021). COVID-19: Data analysis and strategies.
  • Johns Hopkins School of Public Health. (2021). Utilizing reliable sources for pandemic studies.
  • White House Office of Communications. (2021, June 15). White House press briefing on COVID-19. Source